CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

188.48 56.28 31.09 27.01
P/S ratio
0.24 0.25 0.22 0.32
P/FCF ratio
15.20 12.88 12.37 11.25
P/Operating CF
120.19 29.66 21.52 20.85
P/B ratio
1.31 1.33 1.18 1.66
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.38 0.38 0.35 0.43
EV/EBITDA
9.86 10.31 8.78 9.70
EV/Operating CF
16.50 14.52 13.81 12.16
EV/FCF
23.88 19.79 19.30 15.29
Quick Ratio
0.59 0.57 0.61 0.62
Current Ratio
0.83 0.84 0.87 0.87
Net Debt/EBITDA
14.95 16.56 8.85 8.14
Debt/Assets
25.78% 25.47% 24.95% 24.20%
Debt/Equity
0.90 0.86 0.81 0.77
Asset Turnover
1.55 1.59 1.60 1.62
Operating CF/Net income
(0.20) 1.15 1.44 2.13
Capex/Depreciation
(0.10) (0.68) (0.76) (0.61)
Interest Coverage
(4.09) 2.68 6.05 6.21
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.44 0.44 0.44 0.43
Share Based Compensation of Revenue
0.13% 0.13% 0.26% 0.17%
Graham Net Nets
(1.10) (1.03) (1.10) (0.74)
Graham Number
22.77 43.45 56.30 73.37
Earnings Yield
0.53% 1.78% 3.22% 3.70%
Free Cash Flow Yield
6.58% 7.76% 8.09% 8.89%
Revenue per Share
81.06 83.42 78.89 82.95
Operating CF per Share
0.63 2.68 3.34 4.96
Capex per Share
(0.55) (0.62) (0.67) (0.54)
Free Cash Flow per Share
0.08 2.06 2.67 4.42
Cash per Share
8.85 8.36 9.27 10.91
Shareholders Equity per Share
57.61 59.50 60.99 62.47
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
57.61 59.50 60.99 62.47
Free Cash Flow
98.00 2,606.00 3,400.00 5,654.00
Working Capital
(15,586.00) (13,978.00) (11,589.00) (11,695.00)
Capital Expenditures
(698.00) (784.00) (849.00) (691.00)
Net Current Asset Value
(105,108.00) (103,442.00) (100,520.00) (98,523.00)
EV/EBIT
30.57 33.16 23.92 21.69
Capex to Sales
0.01 0.01 0.01 0.01
Price to Operating Income
19.46 21.58 15.32 15.96
Other line items
Average Receivables
40,018.00 38,124.00 40,308.50 40,480.00
Average Payables
16,738.50 16,766.50 16,728.00 17,212.50
Average Inventory
18,305.50 18,676.50 17,577.50 17,534.50
Average Assets
253,877.00 253,376.50 254,279.50 256,055.50
Average Common Equity
74,108.00 75,556.00 77,373.50 78,725.00

Fold the line items

Columns are period end dates